Atlas Venture Associates X, LLC
CIK 1742765 · last filed 2026-02-09
Atlas Venture Associates X, LLC is a corporate insider who has filed 7 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for GBIO, was dated Feb 9, 2026. Across all open-market trades the lifetime net is −$29.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $870.4M across reported positions. The firm reports its address in Cambridge, MA. 38 SEC filings were submitted jointly with ATLAS VENTURE ASSOCIATES X, L.P.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
IRON price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
10TH FLOOR
CAMBRIDGE, MA 02139
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Generation Bio Co. (GBIO) Delisted | 10%+ Owner | 0 | $5.34 | $0 | -$3.51M | 3 | 2026-02-09 |
| IRON | 10%+ Owner | 2,235,846 | $76.35 | $170.71M | -$22.19M | 2 | 2024-01-12 |
| KYMR | 10%+ Owner | 5,858,262 | $119.44 | $699.74M | -$3.82M | 1 | 2023-01-13 |
| Tectonic Therapeutic, Inc. (AVRO) Delisted | 10%+ Owner | 396,373 | $16.80 | $6.66M | $0 | 1 | 2018-06-25 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| GBIO | Direct | 0 | — | 2026-02-09 |
| AVAO I LP See footnote |
0 | — | 2026-02-09 | |
| Total | 0 | |||
| IRON | Direct | 1,449,686 | 64.8% | 2024-01-12 |
| Atlas Venture Opportunity Fund I, L.P. See footnote |
786,160 | 35.2% | 2024-01-12 | |
| Total | 2,235,846 | |||
| KYMR | Direct | 4,968,114 | 84.8% | 2023-01-13 |
| Atlas Venture Opportunity Fund I, L.P. See footnote |
890,148 | 15.2% | 2023-01-13 | |
| Total | 5,858,262 | |||
| AVRO | Atlas Venture Fund X. The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. See Footnote |
396,373 | 100.0% | 2018-06-25 |
| Total | 396,373 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-09 | Generation Bio Co. (GBIO) Delisted | U | −827,946 | $0 | EDGAR |
| 2024-01-12 | IRON | Sell (S) | −50,000 | -$3.20M | EDGAR |
| 2023-09-18 | IRON | Sell (S) | −357,449 | -$18.99M | EDGAR |
| 2023-01-13 | KYMR | Sell (S) | −126,474 | -$3.82M | EDGAR |
| 2021-09-24 | Generation Bio Co. (GBIO) Delisted | Sell (S) | −134,998 | -$3.51M | EDGAR |
| 2020-06-18 | Generation Bio Co. (GBIO) Delisted | Conv (C) | +10,040,032 | $0 | EDGAR |
| 2018-06-25 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Conv (C) | +4,756,478 | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).